Related by context. All words. (Click for frequent words.) 70 analyst Jim Reddoch 69 analyst Glenn Novarro 69 David Amsellem 68 Bret Holley 68 Annabel Samimy 68 analyst Jonathan Aschoff 67 Phil Nalbone 65 analyst Jim Birchenough 65 analyst Geoffrey Meacham 65 Cory Kasimov 65 analyst Raj Denhoy 64 Gbola Amusa 64 Dhulsini de Zoysa 64 Yaron Werber 64 Bruce Cranna 64 Mark Monane 64 Raj Denhoy 64 analyst Ken Trbovich 64 analyst Bruce Cranna 64 Edward Tenthoff 64 analyst Robert Cihra 63 Joshua Schimmer 63 analyst Joanne Wuensch 63 analyst Mark Monane 63 Akhtar Samad 63 analyst Lawrence Keusch 63 Lawrence Keusch 63 Joel Sendek 63 Dr. Jim Birchenough 62 Jerry Doctrow 62 Eric Ende 62 Leerink Swan 62 Joanne Wuensch 62 Jami Rubin 62 Sam Fazeli 62 analyst Randall Stanicky 62 Leerink Swann 62 Piper Jaffray PJC 62 analyst Geoffrey Porges 62 analyst Liana Moussatos 61 Steven Harr 61 Leerink 61 analyst Cory Kasimov 61 Bruce Nudell 61 Jim Birchenough 61 Jonathan Aschoff 61 Jason Kolbert 61 Daniel Berenbaum 61 Jim Reddoch 61 Bert Hazlett 61 Jason Kantor 60 Ken Cacciatore 60 analyst Glenn Reicin 60 analyst Bruce Nudell 60 Matt Miksic 60 Jason Gurda 60 analyst Mark Schoenebaum 60 Suraj Kalia 59 Tao Levy 59 Jeffrey Frelick 59 David Turkaly 59 Joseph Pantginis 59 Monane 59 analyst Emme Kozloff 59 analyst Gbola Amusa 59 Liana Moussatos 59 analyst Yaron Werber 59 analyst Junaid Husain 59 Mark Schoenebaum 59 Geoff Porges 59 Glenn Novarro 59 Hamed Khorsand 59 analyst Mehdi Hosseini 59 Jon Lecroy 59 Roopesh Patel 59 analyst Rommel Dionisio 59 reaffirmed Outperform rating 59 Ittai Kidron 59 Amit Hazan 59 Reiterates Outperform 58 analyst Shaul Eyal 58 analyst Laura Champine 58 Ananda Baruah 58 Reiterates Neutral Rating 58 analyst Dinesh Moorjani 58 Sara Michelmore 58 Cantor Fitzgerald reiterates 58 analyst Amit Bhalla 58 Carl Seiden 58 analyst Shebly Seyrafi 58 Resumes Coverage 58 Inc CYBX 58 Geoffrey Meacham 58 JoAnne Feeney 58 analyst Jeff Fidacaro 58 analyst Phillip Nalbone 58 Yair Reiner 58 ANALYST TAKE Stifel Nicolaus 58 Reiterates Hold 58 analyst Sapna Srivastava 58 Chris Shibutani 58 Kochnover 58 Ajit Pai 58 Denhoy 58 Larry Biegelsen 58 analyst Tore Svanberg 58 Kalpesh Kapadia 58 Moussatos 58 Ronny Gal 58 analyst Kristine Koerber 58 SG Cowen 58 CE Unterberg 57 Oppenheimer 57 Thom Gunderson 57 Justin Hott 57 Suntrust Robinson Humphrey 57 Healthcare Conf 57 Jeffrey Holford 57 Maintains Neutral 57 Reiterates Buy 57 Mark Bacurin 57 Cochran Caronia 57 analyst Maged Shenouda 57 analyst Ajit Pai 57 Keay Nakae 57 Analyst Rebecca Arbogast 57 Analysts Initiate Coverage 57 Lawrence Biegelsen 57 Andrew Vaino 57 Todd Bault 57 Matthew DiFrisco 57 Rating Maintained 57 Jon LeCroy 57 Eric Coldwell 57 Gary Nachman 57 analyst Tim Savageaux 57 analyst Jami Rubin 57 BWS Financial 57 Lauren Cooks Levitan 57 Isaac Ro 57 Rating Reiterated 57 Natixis Bleichroeder analyst 57 Wells Fargo Initiates Coverage 57 Lazard Capital 57 Avik Roy 57 Geoffrey Porges 57 analyst Joseph Altobello 56 Oppenheimer OPY 56 Piper Jaffrey 56 Analysts Downgrade 56 Glenn Reicin 56 analyst Hari Sambasivam 56 analyst Gurinder Kalra 56 JMP Securities downgraded 56 Rachael Rothman 56 Reiterates Buy Rating 56 Reiterates Hold Rating 56 William Plovanic 56 Simos Simeonidis 56 JMP Securities downgrade 56 Analyst Gene Munster 56 Jay Deahna 56 Analyst Toni Sacconaghi 56 Geoff Meacham 56 Kevin Ellich 56 analyst Randal Konik 56 April Scee 56 Olav Zilian 56 analyst Edwin Mok 56 BernsteinResearch 56 Molowa 56 analyst Jeffrey Fidacaro 56 analyst Jesse Pichel 56 Trevor Polischuk 56 analyst Simos Simeonidis 56 Stifel Nicholaus 56 Matt DiFrisco 56 Betsy Van Hees 56 Ahmar Zaman 56 Piper Jaffray 55 ANALYST TAKE Jefferies 55 Gets Downgraded 55 Broadpoint.AmTech analyst 55 Maintains Hold 55 analyst Rebecca Runkle 55 analyst Alex Gauna 55 George Grofik 55 analyst Uche Orji 55 Dr. Joshua Schimmer 55 Reiterate Buy rating 55 analyst Peter Misek 55 Saftlas 55 Gene Munster Piper Jaffray 55 analyst Ananda Baruah 55 Piper Jaffray downgraded 55 Analyst Cody Acree 55 analyst Tim Klasell 55 Navdeep Jaikaria 55 David Molowa 55 Forest Labs FRX 55 Xenoport Inc. 55 Aaron Reames 55 analyst George Grofik 55 analyst Alan Bezoza 55 Assumes Coverage 55 analyst Jason Helfstein 55 Randal Konik 55 Deane Dray 55 Joe Pantginis 55 Maintains Buy 55 Conviction Sell 55 analyst Brad Reback 55 James Kumpel 55 Pantginis 55 Oscar Gruss 55 Jeremy Sussman 55 analyst Andrey Glukhov 55 analyst Ghansham Panjabi 55 analyst Seamus Fernandez 55 FBR Capital Maintains 55 Mike Krensavage 55 ThinkPanmure 55 Therapeutic Competitors 55 analyst Colby Synesael 55 Brean Murray 55 FBR Capital Upgrades 55 analyst Antony Broadbent 55 Nicholas Aberle 55 analyst Dara Mohsenian 55 Rajesh Ghai 55 Donald Fandetti 55 Reik Read 55 ThinkEquity downgraded 55 Jed Dorsheimer 55 Kemp Dolliver 54 Analyst Cai von 54 analyst Jeffrey Klinefelter 54 PiperJaffray 54 Cai von Rumohr 54 Piper Jaffray reiterate 54 ImmunoCellular Therapeutics 54 Alexandra Hauber 54 Katy Huberty 54 analyst Kurt Hallead 54 NASDAQ ACOR 54 Scott Geels 54 Reiterates Strong 54 analyst Allan Mishan 54 Nollenberger Capital 54 Edwards Lifesciences EW 54 analyst Louis Miscioscia 54 Tad Piper 54 Piper Jaffray Reiterates 54 analyst Moshe Katri 54 strategist Brian Belski 54 PiperJaffray analyst 54 James Janesky 54 Jefferies NYSE JEF 54 Broadpoint Amtech 54 analyst William Pecoriello 54 analyst Mahesh Sanganeria 54 analyst Mark Lipacis 54 Feltl & 54 Jeff Fidacaro 54 Lowers Estimates 54 Ken Trbovich 54 Kash Rangan 54 ThinkEquity 54 Analysts Begin Coverage 54 CE Unterberg Towbin 54 analyst Romit Shah 54 Cannacord Genuity 54 Louis Miscioscia 54 analyst Yair Reiner 54 analyst Randy Binner 54 Christopher Danely 54 Kathryn Huberty 54 Kin Ho 54 Tenthoff 54 Amylin Pharma 54 Stacy Rasgon 54 reaffirmed Market Perform 54 HC Wainwright 54 analyst Ali Dibadj 54 Ian Somaiya 54 Maintains Neutral Rating 54 Jesse Pichel 54 Nasdaq GPRO announced 54 Reiterates Buy rating 54 Joe Osha 54 ANALYST TAKE Lehman Brothers 54 analyst Larry Biegelsen 54 analyst Amit Daryanani 54 Neely JN Tamminga 54 Brean Murray downgrades 54 Nasdaq IPXL 54 Eli Kammerman 53 Darren Lehrich 53 reaffirmed Neutral 53 analyst Christa Quarles 53 BMRN 53 analyst Sasa Zorovic 53 Cannacord Adams 53 analyst Robert Drbul 53 FoxHollow Technologies 53 Jonathan Ruykhaver 53 ANALYST TAKE Goldman Sachs 53 Amylin Eli Lilly 53 Michael Krensavage 53 analyst Tal Liani 53 Biegelsen 53 Sipkin 53 Kaufman Bros 53 analyst Connie Maneaty 53 Stanicky 53 United Therapeutics UTHR 53 Geoff Ruddell 53 RBC Capital NYSE RY 53 CR Bard BCR 53 analyst Srini Pajjuri 53 Suneet Kamath 53 Inc. NASDAQ ITMN 53 Neutral Weight 53 Mark Astrachan 53 analyst Ittai Kidron 53 Jonathan Dorsheimer 53 FBR Capital NASDAQ FBCM 53 analyst Walter Piecyk 53 Amir Rozwadowski 53 NASDAQ ADLR 53 Neely Tamminga 53 A. Sasa Zorovic 53 AmTech Research 53 RBC Capital Mkts Reiterate 53 ANALYST TAKE Bear Stearns 53 analyst Elemer Piros 53 Tobias Levkovich 53 Ladenburg Thalman 53 Randall Stanicky 53 Maintains Buy Rating 53 Ambrish Srivastava 53 Ardour Capital 53 Claudia Shank Hueston 53 Brean Murray upgrades 53 Broadpoint AmTech 53 analyst Dorothy Lakner 53 Friedman Billings reiterate 53 Nikos Theodosopoulos 53 Leerink Swann analyst 53 Natexis Bleichroeder 53 Brad Reback 53 Momenta Pharmaceuticals MNTA 53 Michael Masdea 53 Capstone Investments 53 Miller Tabek 53 Claude Camire 53 Dr. Yaron Werber 53 Stifel Nicholas 53 analyst Christopher Svezia 53 Rob Cihra 53 analyst Bijan Moazami 53 ThinkEquity Partners LLC 53 Suresh Balaraman 53 Chris Umiastowski 52 Drickamer 52 Mahesh Sanganeria 52 Jan Wald 52 Rod Bourgeois 52 Medtronic MDT 52 Muken 52 Kevin Scotcher 52 analyst Matthew DiFrisco 52 Maintains Outperform Rating 52 John Calcagnini 52 SG Cowen Securities 52 analyst Anthony Chukumba 52 Joshua Raskin 52 Vijay Rakesh 52 Jay Vleeschhouwer 52 analyst Ambrish Srivastava 52 Medicis Pharma 52 Michael Rehaut 52 Gary Hsueh 52 Nasdaq IDIX 52 NASDAQ ALXN 52 Duane Grubert 52 AUXL 52 Ehud Gelblum 52 Maintains Overweight 52 Al Kaschalk 52 Sepracor SEPR 52 analyst Jason Napodano 52 Analysts Reiterate 52 Auriga USA 52 Stryker NYSE SYK 52 George Staphos 52 Piper Jaffray Upgrades 52 Satya Chillara 52 Karl Heinz Scheunemann 52 Cubist Pharma 52 analyst Ashwin Shirvaikar 52 analyst Patrick Walravens 52 Insituform Technologies INSU 52 analyst Richard Kugele 52 NASDAQ QCOR 52 Jeffrey Bencik 52 Maintains Hold Rating 52 Raises PT 52 Destin Tompkins 52 analyst Jason Gurda 52 Simona Jankowski 52 Schwab Soundview 52 Amit Daryanani 52 Edlain Rodriguez 52 Andreas Theisen 52 William Tanona 52 Barclays Maintains 52 NuVasive NUVA 52 Sanjiv Wadhwani 52 FOXH 52 analyst Kemp Dolliver 52 analyst Maynard Um 52 Charles Minervino 52 Sector Outperformer 52 Ingrid Ebeling 52 peerperform 52 Grasher 52 Sterling Auty 52 analyst Tristan Gerra 52 Matthew Heimermann 52 Vishal Shreedhar 52 W. Ruttenbur 52 newratings.com Analyst Jonathan Aschoff 52 BGB Securities 52 analyst Alexandra Hauber 52 IVGN 52 OGXI 52 Gerard Klauer Mattison 52 analyst Steven Wieczynski 52 analyst Nigel Dally 52 NASDAQ GPRO 52 Atsushi Seki 52 Jeff Klinefelter 52 analyst Youssef Squali 52 Arthrocare 52 analyst Peter Lisnic 52 Inc. NASDAQ EVVV 52 Sanganeria 52 Ajay Kejriwal 52 Oppenheimer NYSE OPY 52 SEPR 52 analyst Kathryn Huberty 52 WBB Securities LLC 52 Tellabs Presentation 52 analyst Daniel Renouard 52 WR Hambrecht analyst 52 David Hochstim 51 Inc. NASDAQ ELGX 51 Douglas Anmuth 51 analyst Pablo Zuanic 51 Vertex VRTX 51 analyst Michael Exstein 51 analyst Richard Fetyko 51 Mintz Levin Represents 51 Plovanic 51 Leerink analyst 51 TSRX 51 Elan Tysabri 51 Seattle Genetics SGEN 51 NASDAQ ONXX 51 Keybanc 51 Tore Svanberg 51 Inc. MDT.N 51 Lowers PT 51 analyst Mitch Kummetz 51 orthopedic implant maker 51 Robert Koort 51 Dorothy Lakner 51 ADRX 51 analyst Benjamin Reitzes 51 Nasdaq AVNR 51 analyst Chad Friess 51 Christa Quarles 51 QDEL 51 Freidman Billings Ramsey 51 Doug Sipkin 51 analyst Simona Jankowski 51 Uche Orji 51 NASDAQ VRTX 51 Kenneth Muth 51 Gary Giblen 51 analyst Satya Chillara 51 analyst Vivek Arya 51 Tony Clapsis 51 Begin Coverage 51 Attention Syndicate Prospectus 51 analyst Thomas Filandro 51 analyst Kirk Materne 51 Punk Ziegel 51 C. Bernstein 51 John DiFucci 51 Holger Blum 51 WR Hambrecht reiterate 51 Kenji Masuzoe 51 Wedbush 51 Raises Estimates 51 Sector Outperform 51 Wedbush Maintains 51 reinitiates coverage 51 Swiss brokerage Helvea 51 Arnie Ursaner 51 analyst Cody Acree 51 Nasdaq OMRI 51 Paul Mansky 51 Kristine Koerber 51 Anthony Bucalo 51 Acorda Therapeutics ACOR 51 analyst Jeffrey Zekauskas 51 Elemer Piros 51 Analyst Tristan Gerra 51 NASDAQ SLXP 51 analyst Tavis McCourt 51 Momenta Pharmaceuticals Inc 51 Hibernia Southcoast Capital 51 Helene Wolk 51 Brian Gesuale 51 NASDAQ REGN 51 Broadpoint Capital 51 Karen Boodram 51 Liisa Bayko 51 Scott Mushkin 51 NASDAQ BMRN 51 ThinkEquity LLC 51 QCOR 51 NASDAQ ZIOP 51 Luke Folta 51 Benjamin Schachter 51 Savvas Neophytou 51 Small Cap Institutional Investor 51 Sol Barer 51 Barclays Capital Reiterate Overweight 51 Therapeutic Competitors companiesandmarkets.com adEgemonye 51 Eyetech Pharmaceuticals 51 IG HCR ;) CO 51 analyst Annabel Samimy 51 Inc Therapeutic Competitors 51 Ann Duignan 51 Becton Dickinson BDX 51 Constance Maneaty 51 BioCentury NewsMakers 51 Ben Reitzes 51 analyst Charles Boorady 51 Jeff Kvaal 50 Sanford Bernstein 50 Douglas Sipkin 50 Matthew Borsch 50 Maintains Outperform 50 Regeneron Pharma 50 MEDACorp 50 Boosts Estimates 50 Andy Kaplowitz 50 Ariad Pharmaceuticals 50 Romit Shah 50 Simulcast Presentation 50 Medivation Inc 50 Brett Manderfeld 50 Carla Antunes da Silva 50 FBR Capital Reiterates 50 Biomarin 50 Tristan Gerra 50 Phillip Nalbone 50 Ehrenkrantz King Nussbaum 50 Stelios Papadopoulos 50 analyst Irene Nattel 50 Craig Hallum 50 Biogen Nasdaq BIIB 50 Alain Karaoglan 50 Daniel Meron 50 Charlie Di Bona 50 Leerink Swan analyst 50 Allan Mishan 50 ANALYST TAKE JPMorgan 50 Canaccord Genuity 50 Atherogenics 50 Zekauskas 50 Brigantine Advisors 50 Jordan Estra 50 Piper Jaffray reiterates 50 Janney Montgomery 50 Piper Jaffray Initiates Coverage 50 analyst Christopher Danely 50 Curtis Shauger 50 Douglas Harned 50 Varian Semi 50 Inhibitex INHX 50 Audio Webcast Presentation 50 analyst Mark Swartzberg 50 Suji De Silva 50 Inc. Nasdaq GLCH 50 Birgit Kulhoff 50 UBS Initiates Coverage 50 Sector Performer 50 Nasdaq SLXP 50 Darren Aftahi 50 analyst Edlain Rodriguez 50 Jonah Shacknai 50 ONXX 50 Jay Gelb 50 Funtleyder 50 JMP Securities reiterates 50 Isis Pharma 50 Steven Burakoff 50 Dmitry Silversteyn 50 Sumit Dhanda 50 Adam Klauber 50 Piper Jaffray downgrades 50 CapStone Investments 50 marketperform 50 CNMD 50 Y. Edwin Mok 50 Simeonidis 50 Peer Perform rating 50 Inc. Endures Analyst 50 analyst Hamed Khorsand 50 Jason Avilio 50 Scot Ciccarelli 50 strategist Bruce Bittles 50 Ulrich Huwald 50 Krensavage 50 analyst Alexander Peterc 50 analyst Edward Yruma 50 Brion Tanous 50 Nasdaq ONXX 50 Jefferies Quarterdeck division 50 Jon Kamp 50 LifeTech Capital 50 analyst Ross Muken 50 Stephen Tusa 50 Eli Lilly NYSE LLY 50 Thoratec Presentation 50 FBR Capital Markets FBCM 50 Auxilium Pharma 50 Lazard Capital Markets 50 AstraZeneca AZN.ISE 50 analyst Tony Wible 50 Gilad Alper 50 Bristol Myers BMY 50 Analyst Dick Bove 50 anlayst 50 KNSY 50 Craig Siegenthaler 50 Mako Surgical 50 Tim Klasell 50 Tahira Afzal 50 NYSE MRX 50 Semtech SMTC 50 Ursaner 50 analyst Frank Mitsch 50 Analyst Safa Rashtchy 50 COWN 50 Nasdaq ZIOP 50 Equal Weight rating 50 Jesse Tortora 50 ANALYST TAKE Merrill Lynch 50 William Pecoriello 50 Technology XLK Bearish 50 Merriman Curhan Ford 50 Nabi Biopharmaceuticals NABI 50 Rule Breakers pick 50 Erika Maschmeyer 50 Piper Jaffray nyse PJC 50 Rommel Dionisio 50 Xenoport 50 Quynh Pham 50 Matthew Kather 50 analyst Sara Michelmore 50 Charles DiBona 50 Wendell Zerb 50 Anna Torma 49 J.P. Morgan Healthcare 49 RBC NYSE RY 49 AMAG Pharma 49 Robinson Humphrey 49 NASDAQ ARIA 49 analyst Bernard Sosnick 49 Moshe Katri 49 Second Annual SIGnificant 49 Jeffrey Fidacaro 49 Matthew Sheerin 49 Thomas Weisel 49 GILD GILD 49 Kenneth Zaslow 49 Richard Kugele 49 analyst Mario Mendonca 49 Shiv Kapoor 49 Joel Fishbein 49 Joshua Shanker 49 Francois Trahan 49 Amylin AMLN 49 Mark Edelstone 49 Robert Lacoursiere 49 Amylin Pharmaceuticals Nasdaq AMLN 49 analyst Ehud Gelblum 49 ALTH 49 Safi Bahcall Ph.D. 49 Diversified Industrials 49 Nasdaq BMRN 49 William F. Tanona 49 RBC Capital 49 Zimmer ZMH 49 MYGN 49 analyst Elizabeth Osur 49 Ana Gupte 49 WR Hambrecht 49 AMLN 49 analyst Tom Wolzien 49 Joseph Amaturo 49 Bayer BAY.ETR 49 Laura Conigliaro 49 Vertex Pharmaceuticals NASDAQ VRTX 49 Stifel Nicolaus 49 Entegris ENTG 49 analyst Jacques Rousseau 49 Maynard Um 49 Reiterates Sell 49 Underweight rating 49 Charles Strauzer 49 Schoenebaum 49 Maintains Market Perform 49 Piper Jaffray Cos. 49 analyst Gil Luria 49 RDEA 49 analyst Peter Nesvold 49 analyst Constance Maneaty 49 Celgene NASDAQ CELG 49 Fixed Income Strategist 49 Jefferies 49 Biomarin Pharm 49 Company Report companiesandmarkets.com 49 Inc. NASDAQ ACOR 49 Reddoch 49 Barclays Reiterates 49 Scott Krasik 49 Horst Hueniken 49 Christopher Svezia 49 analyst Reik Read 49 Lipacis 49 analyst Jonathan Schildkraut 49 BioMarin Pharma 49 Oxigene 49 Kuni Chen 49 analyst Victor Lazarovici 49 Adams Harkness 49 analyst Julio Quinteros 49 Market Perform 49 Khandaker Partners 49 Ed Yruma 49 Darcy Travlos 49 TolerRx 49 JB Hanauer & 49 analyst Michael Rehaut 49 Manoj Garg 49 analyst Sterling Auty 49 PJ Juvekar 49 Armando Anido 49 Pablo Zuanic 49 BernsteinResearch analyst 49 James McIlree 49 Quintin Lai 49 Johnson Steichen Kinnard 49 RW Baird analyst 49 Tom Cholnoky 49 Mark Liinamaa 49 JMP Securities 49 analyst Mark Wienkes 49 Aegerion Pharmaceuticals Inc. 49 Stuart Muter 49 Phil Skolnick 49 Nasdaq QCOR 49 Glen Yeung 49 Feltl 49 Garo Toomajanian 49 GARP Research 49 Brock Vandervliet 49 Kaufman Bros reiterate 49 Electro Optical Sciences 49 analyst Dan Wantrobski 49 BAS ML 49 B. Nemeroff 49 analyst Silke Stegemann 49 economist Elga Bartsch 49 Christopher Mutascio 49 Anthony Gikas 49 Citi Initiates Coverage 49 Piper Jaffray Maintains 49 Steven Alexopoulos 49 Barry Sine 49 Robert Campagnino 49 analyst Robert Campagnino 49 Daniel Fannon 49 ThinkEquity Partners 49 Industrial XLI Bearish 49 analyst Bill Pecoriello 49 James Manuso 49 Nicholas Landekic 49 Morgan Stanely 49 analyst Rebecca Arbogast 49 Merriman Curhan 49 Canaccord Genuity Maintains Hold 49 Edwin Groshans 49 Wedbush analyst 49 McCamant 49 Thomas Cholnoky 49 CorporateCommunications +#-#-#-# 49 Dominic Valder 49 Andrew Goodsall 49 Eitan Bernstein 49 Bob Drbul 49 analyst Gregory Melich 49 Synta Pharmaceuticals 49 Jeffrey Klinefelter 49 Myriad Genetics NASDAQ MYGN 49 Nasdaq ADLR 49 analyst Kian Abouhossein 49 Marc Cluzel 49 Tudor Pickering 49 Idenix Pharma 49 NASDAQ ANDS 49 Bullish Engulfing Formed 49 Matthew Fassler 49 Claymore Equal Weight 49 Consumer Discretionary XLY Bearish 49 Curagen 49 analyst Subash Chandra 49 Welcomes Analyst 49 Brigantine Advisors analyst 49 NASDAQ VPHM 49 analyst Michael Bruynesteyn 49 MKM Partners analyst 49 Uta Werner 49 Affymax AFFY 49 Drew Matus economist 49 Hologic NASDAQ HOLX 49 analyst Deane Dray 49 Sanford C. Bernstein 49 Frozen Shoulder syndrome 49 Creditsights 49 VERTEX PHARMACEUTICALS 49 Welcomes Analyst Initiation 49 SoundView Technology 49 Rebecca Runkle 49 ANALYST TAKE BMO Capital 49 LMAT 49 Guy Moszkowski 49 Nasdaq SOMX 49 Angiotech Pharmaceuticals 49 Michael Bruynesteyn 49 Energy XLE Bearish 49 Jon Arfstrom 49 analyst Betsy Graseck 49 Financial XLF Bearish 48 Biren Amin 48 Zocor Zetia 48 Medical STJ 48 Co. analyst Ittai 48 Anton Wahlman 48 strategist Teun Draaisma 48 analyst Glen Petraglia 48 JMP Securities reiterate 48 Edwin Mok 48 Charles Boorady 48 Biophan Technologies 48 Adeona Pharmaceuticals 48 Healthcare Tailwinds Conference 48 Deliver Presentation 48 Webcast Presentations 48 Heather Bellini 48 RBC Capital Mkts 48 Sherri Scribner 48 Thoratec THOR 48 Analyst Bill Pecoriello 48 analyst Brent Thill 48 THRX 48 Nasdaq EXAS today 48 Daniel Renouard 48 Edwin Hemwall 48 OPTR 48 Avanir Pharmaceuticals 48 Myriad Genetics MYGN 48 Cyclacel Pharmaceuticals 48 Vioxx Zocor 48 SLXP 48 ConsumerEdge Research 48 Durect Corp. 48 Hulk Caris & 48 Ken Zerbe 48 analyst Stephen Tusa 48 Valeant Pharmaceuticals NYSE VRX 48 DRRX 48 strategist Tony Crescenzi 48 Impax Laboratories IPXL 48 Timothy Arcuri 48 Derek Leckow 48 Randy Binner 48 DXCM 48 Pulte Homes Presentation 48 Eric Martinuzzi 48 Aderis 48 analyst Aldo Mazzaferro 48 analyst Bruce Harting 48 Equalweight 48 analyst Christopher Growe 48 analyst Katherine Styponias 48 Corp BSX.N 48 Teradyne TER 48 Brian Piccioni 48 Matt Nemer 48 Carsten Kunold 48 Pacific Growth Equities 48 3Q Profit Doubles 48 Peter Mirsky 48 Idenix Pharmaceuticals 48 Chief Equity Strategist 48 Dahlman Rose downgraded 48 Johan Eliason 48 SN LN 48 Seamus Fernandez 48 Poalim Sahar 48 Anadys Pharmaceuticals 48 Piper Jaffray initiates 48 Steven Wieczynski 48 Outperform Rating 48 Unterberg Towbin 48 analyst Albert Savastano 48 analyst Des Kilalea 48 Drew Brosseau 48 Rhyee 48 Canaccord Genuity Reiterates Buy 48 analyst Lizabeth Dunn 48 Jeffrey Blaeser 48 Ramon Llamas IDC 48 Ladenburg Thalmann analyst 48 Nasdaq AMAG 48 Lazard Capital reiterate 48 Michael Turits 48 ZIOP 48 Neil Flanzraich 48 Co. analyst Shebly 48 Katharine Wynne 48 Onyx Pharma 48 Nik Modi 48 Leonard Teitelbaum 48 analyst Mark Liinamaa 48 analyst Safa Rashtchy 48 analyst Jason Brueschke 48 Walter Nasdeo 48 Pisetsky 48 CADX 48 Krishna Shankar 48 Nasdaq AUXL 48 J.P. Morgan 48 Steven Milunovich 48 analyst Jeffrey Kvaal 48 Constantine Davides 48 Theo Kitz 48 Ricky Goldwasser 48 Ventrus Biosciences 48 Steve Sakwa 48 Inc. NASDAQ VVUS 48 Peter Goldmacher 48 Standpoint Research downgraded 48 Brandon Dobell 48 Kaumil Gajrawala 48 analyst Curtis Shauger 48 analyst Mark Edelstone 48 Boston Scientific BSX 48 Joseph Osha 48 Nasdaq CYTX 48 UBS Maintains Neutral 48 Farooq Hanif 48 Analyst Les Funtleyder 48 Inc. Nasdaq AFFY 48 Allos Therapeutics Incorporated 48 Kathy Styponias 48 ALXN 48 strategist Elliot Spar 48 analyst Jesse Tortora 48 TownHall Investment 48 Monness Crespi Hardt 48 analyst Vijay Jayant 48 analyst Thilo Wrede 48 OPERATOR Next 48 Nasdaq ANDS 48 Troy Lahr 48 analyst Yuji Fujimori 48 Fulcrum Global 48 Ken Hoexter 48 Plachetka 48 VRTX